Elliott J - Search Results

1

Nonpeptide endothelin receptor antagonists. VII: Binding characteristics of [3H]SB 209670, a novel nonpeptide antagonist of endothelin receptors.

Nambi P, Pullen M, Wu HL, Lee D, Saunders D, Heys R, Aiyar N, Leber J, Elliott J, Brooks D, Ohlstein E, Ruffolo R. Nambi P, et al. Among authors: elliott j. J Pharmacol Exp Ther. 1996 Jun;277(3):1567-71. J Pharmacol Exp Ther. 1996. PMID: 8667224

2

Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands.

Nambi P, Wu HL, Pullen M, Aiyar N, Bryan H, Elliott J. Nambi P, et al. Among authors: elliott j. Mol Pharmacol. 1992 Aug;42(2):336-9. Mol Pharmacol. 1992. PMID: 1325032

3

The selective endothelin ETA receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis.

Ohlstein EH, Arleth A, Bryan H, Elliott JD, Sung CP. Ohlstein EH, et al. Among authors: elliott jd. Eur J Pharmacol. 1992 Apr 10;225(4):347-50. doi: 10.1016/0922-4106(92)90109-9. Eur J Pharmacol. 1992. PMID: 1323478

4

Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetized rat: effect of BQ-123 on systemic haemodynamic responses.

Douglas SA, Elliott JD, Ohlstein EH. Douglas SA, et al. Among authors: elliott jd. Eur J Pharmacol. 1992 Oct 20;221(2-3):315-24. doi: 10.1016/0014-2999(92)90718-j. Eur J Pharmacol. 1992. PMID: 1426008

5

Nonpeptide endothelin receptor antagonists. V: Prevention and reversal of acute renal failure in the rat by SB 209670.

Gellai M, Jugus M, Fletcher T, Nambi P, Ohlstein EH, Elliott JD, Brooks DP. Gellai M, et al. Among authors: elliott jd. J Pharmacol Exp Ther. 1995 Oct;275(1):200-6. J Pharmacol Exp Ther. 1995. PMID: 7562550

6

Pharmacological evidence for the presence of three distinct functional endothelin receptor subtypes in the rabbit lateral saphenous vein.

Douglas SA, Beck GR Jr, Elliott JD, Ohlstein EH. Douglas SA, et al. Among authors: elliott jd. Br J Pharmacol. 1995 Apr;114(8):1529-40. doi: 10.1111/j.1476-5381.1995.tb14936.x. Br J Pharmacol. 1995. PMID: 7599920 Free PMC article.

7

Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670.

Douglas SA, Gellai M, Ezekiel M, Feuerstein GZ, Elliott JD, Ohlstein EH. Douglas SA, et al. Among authors: elliott jd. Hypertension. 1995 Apr;25(4 Pt 2):818-22. doi: 10.1161/01.hyp.25.4.818. Hypertension. 1995. PMID: 7721437

8

In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670.

Douglas SA, Edwards RM, Elliott JD, Ohlstein EH. Douglas SA, et al. Among authors: elliott jd. Br J Pharmacol. 1995 Jan;114(2):405-13. doi: 10.1111/j.1476-5381.1995.tb13241.x. Br J Pharmacol. 1995. PMID: 7881741 Free PMC article.

9

Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.

Nambi P, Elshourbagy N, Wu HL, Pullen M, Ohlstein EH, Brooks DP, Lago MA, Elliott JD, Gleason JG, Ruffolo RR Jr. Nambi P, et al. Among authors: elliott jd. J Pharmacol Exp Ther. 1994 Nov;271(2):755-61. J Pharmacol Exp Ther. 1994. PMID: 7965793

10

Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.

Ohlstein EH, Beck GR Jr, Douglas SA, Nambi P, Lago MA, Gleason JG, Ruffolo RR Jr, Feuerstein G, Elliott JD. Ohlstein EH, et al. Among authors: elliott jd. J Pharmacol Exp Ther. 1994 Nov;271(2):762-8. J Pharmacol Exp Ther. 1994. PMID: 7965794

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,097 results

Search Page

Filters